Symbicort - Budesonide with formoterol (1)
AstraZeneca
Description
Long-acting selective beta2 agonist with corticosteroid.
Symbicort 100/3 pressurised inhaler
Asthma, maintenance therapy
• Child 12–17 years: Initially 2–4 inhalations twice daily; reduced to 1 inhalation daily, dose reduced only if control is maintained.
• Adult: Initially 2–4 inhalations twice daily, increased if necessary up to 8 inhalations twice daily; reduced to 1 inhalation daily, dose reduced only if control is maintained.
Asthma, maintenance and reliever therapy
• Over 12 years: Maintenance 4 inhalations daily in 1–2 divided doses, increased if necessary up to 4 inhalations twice daily; 2 inhalations as required for relief of symptoms, increased if necessary up to 12 inhalations as required, usual max. 16 inhalations per day; up to 24 inhalations daily can be used for a limited time under medical supervision.
Symbicort 200/6 Pressurised inhaler
COPD
• Adult: 2 inhalations twice daily.
Indications
Maintenance and reliever therapy for asthma and treatment of COPD.
Preparations Available
Pressurised inhalation
Sizes Available
Pressurised inhalation
Symbicort 100 mcg/3 mcg/dose, 120 doses
Symbicort 200 mcg/6 mcg/dose, 120 doses
More on: Corticosteroids , Budesonide , Bronchodilators , Compound preparations